comparemela.com

Latest Breaking News On - Mark saldanha - Page 1 : comparemela.com

Marksans Pharma Q4 Results: Profit drops by 4.4% to Rs 78.29 crore, dividend announced

Marksans Pharma Q4 Results: Profit drops by 4.4% to Rs 78.29 crore, dividend announced
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Australia
India
New-zealand
Marksans-pharma
Mark-saldanha
Research-development
Reliance-communications
Tata-steel
Donear-industries
Annual-general-meeting
Managing-director

Marksans Receives USFDA Approval For Guaifenesin Extended-Release Tablets

Marksans Receives USFDA Approval For Guaifenesin Extended-Release Tablets
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

India
Mark-saldanha
Marksans-pharma-ltd
Drug-administration
Marksans-pharma-ltd-on
Orb-health
Abbreviated-new-drug-application
Guaifenesin-extended-release-tablets
Mucinex-extended-release-tablets
Managing-director
Pharma-ltd

Marksans Pharma gains on USFDA nod to flu drug

Gguaifenesin helps loosen phlegm and thin bronchial secretions to rid the bronchial passageways of mucus, the company has said

United-states
Mark-saldanha
Marksans-pharma
Drug-administration
Orb-health
United-states-food
Companies
Usiness-news
Markets

Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)

Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

India
Mark-saldanha
Marksans-pharma
Drug-administration
Marksans-pharma-ltd
Orb-health
Guaifenesin-extended-release-tablets
Abbreviated-new-drug-application
Mucinex-extended-release-tablets
Managing-director
Marksans-pharma-limited

Marksans Pharma Operating Revenue Up By 15.3% To ₹ 500 Cr In Q1FY24

Marksans Pharma Operating Revenue Up By 15.3% To ₹ 500 Cr In Q1FY24
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

United-kingdom
Mark-saldanha
Marksans-pharma
Marksans-pharma-ltd
Managing-director
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.